Glypican 3 antibody (C-Term)
Quick Overview for Glypican 3 antibody (C-Term) (ABIN7467198)
Target
See all Glypican 3 (GPC3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Human
-
Purification
- Affinity purified by Protein G.
-
Immunogen
- Recombinant protein encompassing a sequence within the C-terminus region of human Glypican-3. The exact sequence is proprietary.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Validation: Orthogonal
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.4 mg/mL
-
Buffer
- 1XPBS ( pH 7), 20 % Glycerol, No Preservative
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Glypican 3 (GPC3)
-
Alternative Name
- glypican 3
-
Background
- Glypican 3 , DGSX , GTR2-2 , MXR7 , OCI-5 , SDYS , SGB , SGBS , SGBS1,Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome. [provided by RefSeq]
-
Molecular Weight
- 66 kDa
-
Gene ID
- 2719
-
UniProt
- P51654
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-